Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Sep 8, 2016; 8(25): 1067-1074
Published online Sep 8, 2016. doi: 10.4254/wjh.v8.i25.1067
Table 1 Demographical and clinical characteristics of the chronic hepatitis C patients classified by cluster of differentiation 36 genotype
CD36 genotype
VariableAAAGGGP-value
No. of patients, n (%)22 (30.1)40 (54.8)11 (15.1)---
Age (yr)48.1 ± 11.751.4 ± 11.153.7 ± 15.30.38
Gender (F/M)(12/10)(21/19)(7/4)0.68
BMI (kg/m2)26.6 ± 4.124.9 ± 4.224.4 ± 3.10.52
Duration of infection (yr)26.9 ± 10.125.2 ± 8.125.4 ± 7.40.62
HCV genotype 1, n (%)15 (68.2)27 (67.5)8 (72.7)0.40
HCV genotype 2, n (%)5 (22.7)9 (22.5)3 (27.3)
HCV genotype 3, n (%)2 (9.1)4 (10)0 (0)
Table 2 Daily dietary intake of the chronic hepatitis C patients classified by cluster of differentiation 36 genotype
CD36 genotype
VariableReference valuesAAAGGGP-value
Total calories-2531.3 ± 301.31902.5 ± 396.11873.5 ± 345.70.021a
CH (%)50-6055.4 ± 10.554.3 ± 8.953.2 ± 6.40.76
Protein (%)1517.2 ± 4.616.3 ± 3.916.4 ± 2.90.81
Fat (%)< 3034.9 ± 7.527.5 ± 7.224.9 ± 1.10.001299a
SFA (%)< 716.1 ± 6.18.1 ± 3.28.4 ± 2.70.2 × 10-6a
MUFA (%)2013.1 ± 3.412.8 ± 7.612.1 ± 5.40.94
PUFA (%)108.8 ± 6.55.6 ± 4.25.2 ± 1.30.11
Table 3 Daily intake of food group servings in chronic hepatitis C patients classified by cluster of differentiation 36 genotype
CD36 genotype
VariableReference valuesAAAGGGP-value
Sugars0-35.7 ± 4.35.5 ± 4.85.2 ± 4.10.85
Meat2-35.7 ± 1.65.1 ± 2.84.4 ± 2.20.15
Fruits2-42.0 ± 1.81.7 ± 0.91.4 ± 1.10.43
Vegetables3-52.1 ± 1.61.9 ± 1.11.6 ± 0.80.42
Fats0-36.5 ± 1.74.3 ± 3.13.9 ± 2.20.0032071
Milk1-31.0 ± 0.70.8 ± 0.70.8 ± 0.90.86
Legumes1-21.0 ± 0.70.9 ± 0.70.8 ± 0.70.88
Cereals6-1110.3 ± 5.49.6 ± 5.89.0 ± 5.10.77
Table 4 Biochemical profile of the chronic hepatitis C patients classified by cluster of differentiation 36 genotype
CD36 genotype
VariableAAAGGGP-value
Glucose (mg/dL)109.5 ± 59.3106.7 ± 42.997.4 ± 19.80.78
TC (mg/dL)146.8 ± 35.1162.2 ± 44.2157.8 ± 51.10.40
TG (mg/dL)112.8 ± 43.3140.8 ± 60.8142.3 ± 51.10.30
HDL-c (mg/dL)42.7 ± 15.140.4 ± 13.133.8 ± 9.80.21
LDL-c (mg/dL)83.1 ± 28.895.4 ± 42.6101.1 ± 42.60.44
VLDL-c (mg/dL)22.6 ± 8.728.2 ± 12.128.9 ± 10.10.27
ALT (IU/L)93.8 ± 42.673.4 ± 73.171.5 ± 46.40.38
AST (IU/L)91.7 ± 41.361.5 ± 40.369.8 ± 53.90.0281
GGT (IU/L)85.9 ± 56.266.4 ± 40.843.1 ± 33.20.18
Table 5 Kilopascals and aspartate aminotransferase to platelet ratio index score values by the severity of liver fibrosis among chronic hepatitis C patients
VariableMild fibrosisAdvanced fibrosisP-value
No. of patients, n (%)35 (47.9)38 (52.1)-
kPa6.5 ± 1.722.7 ± 13.4< 0.001
APRI score0.81 ± 0.331.78 ± 0.53< 0.001
Table 6 Association of the cluster of differentiation 36 genotype with the severity of liver fibrosis among chronic hepatitis C patients
CD36 genotypeMild fibrosis n (%)Advanced fibrosis n (%)Genotype comparisonOdds ratio (95%CI)P-value
AA6 (17.1)16 (42.1)AA vs GG3.20 (0.70-14.52)0.12
AG23 (65.7)17 (44.7)AA vs AG3.60 (1.16-11.15)0.02
GG6 (17.1)5 (13.2)AA vs AG/GG3.51 (1.18-10.45)0.02